CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO) is scheduled to report Q2 earnings on August 5, 2026.
In the most recent quarter (Q1), CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. reported EPS of $-0.20, beating estimates of $-1.00 by 0.80%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. has averaged an EPS surprise of 3.53% and a revenue surprise of 0.00%.
Analyze the earnings history of CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. using advanced sorting and filters.
The chart below shows CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc.'s reported EPS compared to analyst estimates over recent quarters.
The chart below shows CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc.'s reported revenue compared to analyst estimates over recent quarters.
CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
The Actual EPS was $-0.20, which beat the estimate of $-1.00.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-15 | $-0.20 | $-1.00 | 80.0 % |
| Q4 | 2026-04-15 | $-3.23 | $-0.75 | -330.7 % |
| Q3 | 2025-11-19 | $-9.10 | $-4.35 | -109.2 % |
| Q2 | 2025-08-22 | $-61.71 | $-6.21 | -893.7 % |